IsoPlexis Proteomic Product Suite for Autoimmune Inflammation

Application Note

IsoPlexis Proteomic Product Suite for Autoimmune Inflammation

Learn how IsoPlexis’ Functional Proteomics reveals unique secretomic signatures and insights into autoimmune inflammation.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Application Note we discuss:

Cytokine storm and neurological manifestations of COVID-19 in patients

The role of innate immunity in Multiple Sclerosis (MS) pathogenesis

Biomarkers of neurotoxicity and Immune Related Adverse Events (IRAEs)

Altered cytokine production and functional mechanisms of IBD

Polyfunctional cytokine drivers of transplant rejection

App-Note_Proteomic-Product-Suite-for-Autoimmune-Inflammation_IsoPlexis-1

App-Note_Proteomic-Product-Suite-for-Autoimmune-Inflammation_IsoPlexis-2

App-Note_Proteomic-Product-Suite-for-Autoimmune-Inflammation_IsoPlexis-3

App-Note_Proteomic-Product-Suite-for-Autoimmune-Inflammation_IsoPlexis-4

A Deeper Look

More about this Application Note

Overcoming Challenges in Autoimmune Inflammation

An inflammatory response is driven by the inflammatory cytokine contribution from various immune cell types, though it remains challenging to find early biomarkers of inflammatory reaction & autoimmune progression.

Download this App Note to learn how IsoPlexis identifies heterogeneous functional immune cell subsets to help you better understand the biomarkers of autoimmune response and disease progression.

Get the Application Note

Back to the Top